Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
ESTROGENS AND ANDROGENS 1 Estrogens • Natural: Estradiol, estrone & estriol • Conjugated: premarin (estrone and equillin) • Steroidal synthetic: Mestranol & Ethinyl estradiol • Non-steroidal synthetic: Diethylstilbesterol • Rationale for synthetic: to ↑ oralbioavailability, half-life and ↑ feedback inhibition on FSH & LH 2 • Estradiol – Transdermal patch, IM • Oral – Premarin ( Estrone + Equilin) , Estinyl estradiol , Mestranol • Excretion - Renal 3 Estrogens: Clinical Uses • Contraception: ↓ feedback release of gonadotropins • Female Hypogonadism (estrogen + progestin) or ovarian failure • Estrogens for hormone replacement therapy in menopausal women to ↓ bone resorption • Uterine bleeding • Dysmenorrhea • Men with androgen dependent prostate cancer to 4 slow the growth of the cancer cell. • • • • • • • SIDE EFFECT: Nausea Breast tenderness Endometrial hyperplasia Increased skin pigmentation Increased blood coagulation at high doses Increased risk of endometrial cancer unless progestin is added • Breakthrough bleeding • DES clear cell adenocarcinoma of vagina in females exposed to DES in utero. 5 Contraindicated Patients: • With estrogen-dependent neoplasm (e.g. endometrial carcinoma) • At higher risk for or with breast carcinoma that are estrogen dependent • Predisposed to thromboembolic disease 6 SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERMS) • Are non-steroidal compounds that bind to estrogen receptors. • They can act as either agonist, partial agonists and antagonists depending on the tissue 7 • • • • • Tamoxifene: Has various actions depending on the tissue Bone: agonist to prevent bone resorption Breast: antagonist Endometrium: a partial agonist with the risk of increasing endometrial cancer • USES: estrogen dependent breast cancer • SE: Hot flushes, nausea and vomiting 8 Raloxifene • Bone: agonist • Uterus and breast: antagonist • USES: prophylaxis of postmenopausal osteoporosis. • SE: increased risk of DVT, pulmonary embolism 9 Clomiphene • MOA: ↓ feedback inhibition→ ↑FSH and LH • USE: for infertility caused by anovulatory cycle such as those seen in patients with PCOS • Side effect: multiple pregnancies, ovarian enlargement 10 ANTI ESTROGENS • Anastrozole: • MOA: is an aromatase inhibitor, resulting in decreased estrogen synthesis • USE: estrogen-dependent postmenopausal breast cancer. 11 Progestin's • Progestins can be androgenic and antiestrogenic in action • Progesterone: major natural progesterone • Medroxyprogesterone • Norethindrone • 17α-Hydroxyprogesterone • Norgestrel • Desogestrel: devoid of androgenic and antiestrogenic actions 12 Clinical Uses: Progestins Major uses: • hormone contraception : ↑ feedback inhibition esp LH → no ovulation • hormone replacement treatment along with estrogen to decrease endometrial cancer • dysmenorrhea 13 Adverse Effects: Progestins reduce plasma HDL ↑LDL • Breakthrough bleeding • Acne, weight gain and hirsutism (androgenic effect) 14 ANTIPROGESTIN • Mifepristone (RU-486): • Used as an abortifacient, administered with misoprostol (PGE₁) • Also an antiglucocorticoid • SIDE EFFECT: bleeding, GI effects(nausea, vomiting) and abdominal pain 15 Hormonal Contraception • Progestins (Mini pill) only (norethindrone or norgestrel) • Estrogens and progestins (combination pills) • Progestin implants • Post-coital contraception uses estrogen (mestranol or etinyl estradiol) Mechanism of Action: contraception • ovulation-inhibition by suppressing gonadotropins • change in cervical mucus(progesterone) 16 • Drug interaction: p450 inducers ↓ contraceptive effectiveness • Can result in unwanted pregnancies 17 Combined oral contraceptive pill ADVANTAGE DISADVANTAGE Reliable (<1% failure) Taken daily ↓ risk of endometrial and ovarian cancer No protection against STDs ↓ pelvic infections ↑ triglycerides ↓ risk of osteoporosis Depression, weight gain, nausea, hypertension No dysmenorrhea Hypercoagulable state 18 SIDE EFFECTS • • • • • • • • • ESTROGENS: Nausea Bloating Headache Mastalgia Increase skin pigmentation Weight gain Breakthrough bleeding Withdrawal bleeding 19 • • • • • PROGESTIN: Weight gain Hirsutism Acne Increase LDL 20 Adverse Effects of combined ocps • Venous Thromboembolic Disease • breakthrough bleeding • Withdrawal bleeding • RISK FACTORS: Smoking, Increased age 21 ANDROGENS • Testosterone - Cypionate, Enanthate,Propionate • dihydrotestosterone • Fluoxymesterone • Danazol • androstenedione • Nandrolone 22 • • • • USES: Male hypogonadism For anabolic actions to increase muscle mass Illicit use in athletes 23 Replacement therapy in men • • • • • Acne excessive libido & erections, increased muscle & bone mass, aggravation of pre existing prostate cancer. Reduce plasma HDL and increase LDL 24 Gynecological Disorders: Androgens • Danazol • used in the treatment of endometriosis which is the growth of endometrial tissue outside the uterus, especially in the pelvis. 25 SIDE EFFECTS OF ANDROGENS • • • • • • SE: Excessive masculinization Premature closure of epiphysis Aggression Dependence and abuse Depression of menses and hirsutism in women 26 27 Contraindications: Androgenic Steroids • Pregnant women: its teratogenic • Children Androgens - Not used in children • Men with prostatic carcinoma 28 Anti-Androgen • Cyproterone acetate • Flutamide • Finasteride 29 Androgen Suppression & Antiandrogens Androgen Suppression: • Symptomatic Management of prostatic carcinoma • Management of BPH 30 Antiandrogens Conversion Inhibitors Finasteride: • Inhibits 5 alpha reductase • decreases dihydrotestosterone levels in the prostate • Uses – BPH to reduce the size of the prostate and male pattern baldness • Has been replaced by α1 blockers in the symptomatic treatment of BPH 31 Antiandrogens Competitive androgenic Receptor Inhibitors: • Cyproterone & Cyproterone acetate Clinical use: • Women - hirsutism • Men - reduction of sexual drive 32 Antiandrogens Flutamide • Competitive inhibitor of androgens • Used in androgen receptor positive Prostatic Carcinoma 33 Bicalutamide • Effective orally for the treatment of metastatic prostatic cancer. 34